| Antibiotic Resistance in Bacteria | Lifetime | 29 | JP 1 | 99.87 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 51 | JP 1 | 99.64 |
| Vibrio bacteria research studies | Lifetime | 62 | JP 1 | 99.33 |
| Enterobacteriaceae and Cronobacter Research | Lifetime | 30 | JP 1 | 98.76 |
| Infections and bacterial resistance | Lifetime | 19 | JP 1 | 99.15 |
| Antibiotic Use and Resistance | Lifetime | 120 | JP 1 | 99.12 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 149 | JP 2 | 99.11 |
| COVID-19 Clinical Research Studies | Lifetime | 609 | JP 8 | 97.78 |
| Pharmaceutical and Antibiotic Environmental Impacts | Lifetime | 342 | JP 2 | 98.43 |
| Urinary Tract Infections Management | Lifetime | 257 | JP 5 | 98.06 |
| Mycobacterium research and diagnosis | Lifetime | 503 | JP 7 | 97.55 |
| Long-Term Effects of COVID-19 | Lifetime | 863 | JP 11 | 94.65 |
| Bacterial biofilms and quorum sensing | Lifetime | 818 | JP 19 | 95.82 |
| Escherichia coli research studies | Lifetime | 623 | JP 31 | 95.61 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 34 | JP 1 | 99.35 |
| Vibrio bacteria research studies | 2021-2025 | 19 | JP 1 | 97.28 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 40 | JP 1 | 98.43 |
| Antibiotic Use and Resistance | 2021-2025 | 61 | JP 2 | 98.19 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 48 | JP 1 | 97.68 |
| COVID-19 Clinical Research Studies | 2021-2025 | 483 | JP 7 | 97.79 |
| Long-Term Effects of COVID-19 | 2021-2025 | 467 | JP 6 | 95.73 |
| Antimicrobial Resistance in Staphylococcus | 2021-2025 | 423 | JP 13 | 87.99 |
| Urinary Tract Infections Management | 2021-2025 | 544 | JP 26 | 83.10 |
| Mycobacterium research and diagnosis | 2021-2025 | 901 | JP 36 | 83.18 |
| Enterobacteriaceae and Cronobacter Research | 2021-2025 | 98 | JP 2 | 80.63 |
| Streptococcal Infections and Treatments | 2021-2025 | 776 | JP 34 | 77.26 |
| Escherichia coli research studies | 2021-2025 | 514 | JP 17 | 73.96 |
| Infections and bacterial resistance | 2021-2025 | 207 | JP 17 | 64.34 |
| Bartonella species infections research | 2021-2025 | 258 | JP 3 | 40.28 |
| Diphtheria, Corynebacterium, and Tetanus | 2021-2025 | 398 | JP 19 | 29.60 |